At a glance
ClinicalIndex Comparison RecordN/ACompleted· 22 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Microarray Analysis of IFN-Induced Gene Expression in Obese and Non-Obese Patients With Chronic Hepatitis C
In Brief
An observational study for Chronic Hepatitis C and Obesity. Completed, enrolled 22 participants across 1 site.
Detailed Summary
The response rate to interferon-based anti-viral therapy for chronic hepatitis C is lower in patients who are obese. However, it is not clear whether this is related to suboptimal dosing of the medication or alterated response in obese patients. Alterated immune response had been reported in obese patients. The goal of current study is to determine the immune response to interferon in obese compared to non-obese chronic hepatitis C in an tissue culture system.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Hepatitis C, Obesity
CountriesUnited States
CollaboratorsHoffmann-La Roche
Timeline
N/ACompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartNov 2005
First PostedMay 2006
Primary CompletionNov 2007
Study CompletionNov 2008
TodayJul 2026
First PostedMay 5, 2006
Enrollment StartNov 1, 2005
Primary CompletionNov 1, 2007
Study CompletionNov 1, 2008
TodayJul 2, 2026
Enrollment to primary: 2 yearsPosted 20.2 years ago